CuroGens Europa IVS: Financial statements 2018
CVR: 37602736
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
CuroGens Europa IVS (CVR 37602736) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 2,125,013 and a net result of DKK 536 compared with DKK 205,904 the year before. That is a decrease of 18.9% compared with the year before. The profit margin was 0%. Equity in the 2018 report amounted to DKK 636. The solvency ratio was 0.2%.
- Revenue
- DKK 2,125,013
- Gross Profit
- DKK 4,812
- Profit/Loss
- DKK 536
- Equity
- DKK 636
- Total Assets
- DKK 318,195
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
CuroGens Europa IVS has published its annual report for 2017. Revenue came to DKK 2,620,660, and the net result was DKK 205,904.
About CuroGens Europa IVS
CuroGens Europa IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 20 December 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company has 1 employee (2020). In 2020, the company reported revenue of DKK 1,824,494 and a net result of DKK 15,632 compared with DKK -57,502 the year before. Equity in the 2020 report amounted to DKK 44,407.
